Gelatin sponge scaffolds loaded with adipose-derived mesenchymal stem cell secretome enhance full-thickness skin wound healing in rats
Social Determinants of Health,
Vol. 12 (2026),
1 January 2026
,
Page 1-15
https://doi.org/10.22037/sdh.v12i1.51225
Abstract
Background: Skin wounds that are full-thickness present a major clinical problem. Although cell-based treatments have limitations, the secretome of adipose-derived mesenchymal stem cells (ADMSCs) stimulates recovery through paracrine signaling. This study utilized a gelatin sponge scaffold as a biocompatible delivery platform for the ADMSC secretome, creating a cell-free therapeutic system.
Methods: Human ADMSCs were characterized. Their conditioned medium (secretome) was collected and analyzed for key growth factors. Gelatin sponge scaffolds were fabricated by freeze-drying and crosslinking, then loaded with the secretome. Scaffolds were characterized physico-chemically (SEM, FTIR, porosity, degradation). In vitro biocompatibility was tested on dermal fibroblasts. Gelatin/secretome scaffolds, gelatin-only scaffolds, or gauze were used to treat full-thickness excisional wounds in rats (n = 6 per group). Wound closure, histology, collagen, and angiogenesis were evaluated on days 10 and 20.
Results: ADMSCs expressed characteristic markers. The secretome contained hepatocyte growth factor (124.45 pg/mL), basic fibroblast growth factor-2 (42.18 pg/mL), and vascular endothelial growth factor (7.54 pg/mL). Scaffolds showed high porosity (85-90%) and supported high fibroblast viability/proliferation. In vivo, gelatin/secretome scaffolds achieved significantly faster wound closure (87.4 ± 4.3% on day 10; 98.7 ± 1.2% on day 20) versus controls (gelatin: 68.2 ± 5.7% and 92.1%; gauze: 62.5 ± 6.1%). They also promoted superior re-epithelialization, collagen deposition (62.4 ± 5.8%), and neovascularization (32.8 ± 4.6 vessels/field).
Conclusion: Gelatin scaffolds loaded with ADMSC secretome significantly enhance full-thickness wound healing by accelerating closure, improving tissue regeneration, and stimulating angiogenesis. This cell-free platform represents a promising strategy for clinical wound care.
- Adipose Tissue
- Gelatin
- Mesenchymal Stem Cells
- Regenerative Medicine
- Secretome
- Tissue Engineering
- Tissue Scaffolds
- Wound Healing
How to Cite
References
1. Frykberg RG, Banks J. Challenges in the treatment of chronic wounds. Advances in wound care. 2015;4(9):560-582. https://doi.org/10.1089/wound.2015.0635
2. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(1):314-321. https://doi.org/10.1038/nature07039
3. Sen CK. Human wounds and its burden: an updated compendium of estimates. Adv Wound Care (New Rochelle). 2019;8(1):39-48. https://doi.org/10.1089/wound.2019.0946
4. Han G, Ceilley R. Chronic wound healing: a review of current management and treatments. Adv Ther. 2017;34(1):599-610. https://doi.org/10.1007/s12325-017-0478-y
5. Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA. Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med. 2012;1(1):142-149. https://doi.org/10.5966/sctm.2011-0018
6. Mahjoor M, Kalantari H, Afarin R, Fassihi P, Zafari A, Taromchi AH, et al. Regenerative potential of mesenchymal stromal cells in wound healing: a systematic review. Front Cell Dev Biol. 2023;11(1):1245872-86. https://doi.org/10.3389/fcell.2023.1245872
7. Bunnell BA. Adipose tissue-derived mesenchymal stem cells. Cells. 2021;10(1):3433-47. https://doi.org/10.3390/cells10123433
8. Mazini L, Rochette L, Amine M, Malka G. Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs). International journal of molecular sciences. 2019;20(10):2523-34. https://doi.org/10.3390/ijms20102523
9. Hocking AM, Gibran NS. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Experimental cell research. 2010;316(14):2213-9. https://doi.org/10.1016/j.yexcr.2010.05.009
10. Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One. 2008;3(1):1886-98. https://doi.org/10.1371/journal.pone.0001886
11. Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8(8):886-97. https://doi.org/10.3390/cells8080886
12. Prado-Yupanqui JW, Choque-Guevara R, Gonzalez JC. Therapeutic potential on wound healing and cell-free approaches of mesenchymal stem cells secretome. Tissue Eng Regen Med. 2025;22(1):886-97. https://doi.org/10.1007/s13770-025-00660-3
13. Trigo CM, Rodrigues JS, Camões SP, Solá S, Miranda JP. Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?. Journal of Advanced Research. 2025;70(1):103-124. https://doi.org/10.1002/adhm.202402090
14. Mazini L, Ezzoubi M, Malka G. Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19. Stem cell research & therapy. 2021;12(1):1-18. https://doi.org/10.1186/s13287-020-02006-w
15. Hu MS, Borrelli MR, Lorenz HP, Longaker MT, Wan DC. Mesenchymal stromal cells and cutaneous wound healing: a comprehensive review of the background, role, and therapeutic potential. Stem cells international. 2018;2018(1):6901983-98. https://doi.org/10.1155/2018/6901983
16. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic‐Canic M. Growth factors and cytokines in wound healing. Wound repair and regeneration. 2008;16(5):585-601. https://doi.org/10.1111/j.1524-475X.2008.00410.x
17. Ferreira JR, Teixeira GQ, Santos SG, Barbosa MA, Almeida-Porada G, Gonçalves RM. Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning. Frontiers in immunology. 2018;9(1):2837. https://doi.org/10.3389/fimmu.2018.02837
18. Pawitan JA. Prospect of stem cell conditioned medium in regenerative medicine. BioMed research international. 2014;2014(1):965849. https://doi.org/10.1155/2014/965849
19. Gómez-Ferrer M, Villanueva-Badenas E, Sánchez-Sánchez R, Sánchez-López CM, Baquero MC, Sepúlveda P, Dorronsoro A. HIF-1α and pro-inflammatory signaling improves the immunomodulatory activity of MSC-derived extracellular vesicles. International journal of molecular sciences. 2021;22(7):3416. https://doi.org/10.3390/ijms22073416
20. Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. International journal of molecular sciences. 2017;18(9):1852-63. https://doi.org/10.3390/ijms18091852
21. Echave MC, Burgo LS, Pedraz JL, Orive G. Gelatin as biomaterial for tissue engineering. Current pharmaceutical design. 2017;23(24):3567-84. https://doi.org/10.2174/0929867324666170511123101
22. Yao CH, Liu BS, Chang CJ, Hsu SH, Chen YS. Preparation of networks of gelatin and genipin as degradable biomaterials. Materials Chemistry and Physics. 2004;83(2-3):204-208. https://doi.org/10.1016/j.matchemphys.2003.08.027
23. Ghasemian M, Alasvand N, Samadikuchaksaraei A, Bahrami H, Azami M, Ramroudi F, Gharahgheshlagh SN, Nasiri H, Taherkhani S, Milan PB. Comparison of two hemostatic skin adhesive dressings, incorporating multi-metal bioactive glass. Engineered Regeneration. 2025;6(1):54-73. https://doi.org/10.1016/j.engreg.2024.09.003
24. Cao H, Wang J, Hao Z, Zhao D. Gelatin-based biomaterials and gelatin as an additive for chronic wound repair. Frontiers in Pharmacology. 2024;15(1):1398939-48. https://doi.org/10.3389/fphar.2024.1398939
25. Long H, Ma K, Xiao Z, Ren X, Yang G. Preparation and characteristics of gelatin sponges crosslinked by microbial transglutaminase. PeerJ. 2017;5(1):e3665. https://doi.org/10.7717/peerj.3665
26. Campiglio CE, Ponzini S, De Stefano P, Ortoleva G, Vignati L, Draghi L. Cross-linking optimization for electrospun gelatin: challenge of preserving fiber topography. Polymers. 2020;12(11):2472-85. https://doi.org/10.3390/polym12112472
27. Yang G, Xiao Z, Long H, Ma K, Zhang J, Ren X, Zhang J. Assessment of the characteristics and biocompatibility of gelatin sponge scaffolds prepared by various crosslinking methods. Scientific reports. 2018;8(1):1616-37. https://doi.org/10.1038/s41598-018-20006-y
28. Jarquín-Yáñez K, Arenas-Alatorre J, Piñón-Zárate G, Arellano-Olivares RM, Herrera-Enríquez M, Hernández-Téllez B, Castell-Rodríguez AE. Structural effect of different EDC crosslinker concentration in gelatin-hyaluronic acid scaffolds. J. Bioeng. Biomed. Sci. 2016;6(2):182-186. https://doi.org/10.1166/jbt.2016.1537
29. Ni J, He X, Zhao C, Lu L, Chen T, Liu Y, et al. Promotion of hair growth by a conditioned medium from stem cells in a 3D scaffold: a possible clinical trial approach. Arch Dermatol Res. 2024;316(1):227-239. https://doi.org/10.1007/s00403-024-03025-9
30. Zhang Y, Xia L, Zhai Y, Shi Y, Shen J. Mesenchymal stem cell-conditioned medium accelerates skin wound healing in diabetic mice by regulating inflammatory responses and promoting angiogenesis. Front Cell Dev Biol. 2025;13(1): 1659444. https://doi.org/10.3389/fcell.2025.1659444
31. Hivechi A, Milan PB, Modabberi K, Amoupour M, Ebrahimzadeh K, Gholipour AR, Sedighi F, Amini N, Bahrami SH, Rezapour A, Hamidi M. Synthesis and characterization of exopolysaccharide encapsulated PCL/gelatin skin substitute for full-thickness wound regeneration. Polymers. 2021;13(6):854. https://doi.org/10.3390/polym13060854
32. Sheng W, Song Q, Su X, Lu Y, Bai Y, Ji F, Zhang L, Yang R, Fu X. Sodium alginate/gelatin hydrogels loaded with adipose‐derived mesenchymal stem cells promote wound healing in diabetic rats. Journal of Cosmetic Dermatology. 2023;22(5):1670-1679. https://doi.org/10.1111/jocd.15631
33. Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15(6):641-648. https://doi.org/10.1016/j.jcyt.2013.02.006
34. Baer PC, Geiger H. Adipose‐derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem cells international. 2012;2012(1):812693. https://doi.org/10.1155/2012/812693
35. Dominici ML, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. https://doi.org/10.1080/14653240600855905
36. Prawitasari S, Yusa E, Aini QN, Hamidah B, Firidin SV. Derived MSCs over passages 6 to 9: a flow cytometry analysis of umbilical cord-derived MSC surface markers. Clin Biol Sci J. 2024;4(1):51-59. https://doi.org/10.58524/cbsj.v4i1.365
37. Gu Q, Tomaskovic‐Crook E, Wallace GG, Crook JM. 3D bioprinting human induced pluripotent stem cell constructs for in situ cell proliferation and successive multilineage differentiation. Advanced healthcare materials. 2017;6(17):1700175-89. https://doi.org/10.1002/adhm.201700175
38. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. science. 1999;284(5411):143-147. https://doi.org/10.1126/science.284.5411.143
39. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Molecular biology of the cell. 2002;13(12):4279-95. https://doi.org/10.1091/mbc.e02-02-0105
40. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. Journal of cellular biochemistry. 2006;98(5):1076-84. https://doi.org/10.1002/jcb.20886
41. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109(10):1292-1298. https://doi.org/10.1161/01.CIR.0000121425.42966.F
42. Kota DJ, Wiggins LL, Yoon N, Lee RH. TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity. Diabetes. 2013;62(6):2048-2058. https://doi.org/10.2337/db12-0931
- Abstract Viewed: 39 times
- PDF Downloaded: 24 times